Efficiency and safety of opioid therapy of chronic pain syndrome in patients with cancer of the refractory iron: clinico-pathogenetic features
https://doi.org/10.31146/1682-8658-ecg-170-10-45-51
Abstract
Aim. To study the influence of clinical and pathogenetic factors in patients with pancreatic cancer on the efficacy and safety of analgesic therapy of chronic pain syndrome.
Materials and methods. Clinical features of formation of chronic pain syndrome predetermining the efficacy and safety of analgesic therapy were studied in 82 patients with pancreatic cancer.
Results. The efficacy and safety of opioids in the comparison groups of morphine sulfate, fentanyl TTC and oxycodone / naloxone in patients with pancreatic cancer was shown.
About the Authors
O. P. Bobrova
Krasnoyarsk State Medical University; Krasnoyarsk Regional Cancer Centre
Russian Federation
Russian Federation
N. A. Schneider
National Medical Research Center of Psychiatry and Neurology
Russian Federation
Russian Federation
M. M. Petrova
Krasnoyarsk State Medical University
Russian Federation
Russian Federation
D. V. Dmitrenko
Krasnoyarsk State Medical University
Russian Federation
Russian Federation
S. K. Zyryanov
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
S. N. Zobova
Krasnoyarsk State Medical University; Federal Research Center “Krasnoyarsk Scientific Center Siberian Branch of the Russian Academy of Sciences”
Russian Federation
Russian Federation
References
1. Невзорова Д.В., Абузарова Г. Р. Клинические рекомендации: хронический болевой синдром у взрослых пациентов, нуждающихся в паллиативной медицинской помощи // Терапия, 2017, 32, с. 69–75. Nevzorova D. V., Abuzarova G. R. Clinical recommendations: chronic pain syndrome in adult patients in need of palliative care. Th erapy, 2017, 32, pp. 69–75 (in Russian).
2. Lahoud M.J., Kourie H. R., Antoun J. Road map for pain management in pancreatic cancer: A Review. World J Gastrointest Oncol. 2016, 8(8), pp.599–606. doi: 10.4251/wjgo.v8.i8.599
3. Dobosz Ł., Kaczor M., Stefaniak T. J. Pain in pancreatic cancer: review of medical and surgical remedies. ANZ J Surg. 2016, 86(10), рp. 756–761. doi: 10.1111/ans.13609.
4. Клинические Практические Рекомендации KDIGO 2012 по диагностике и лечению хронической болезни почек // Нефрология и диализ. – 2017, • Т. 19, № 1. – с. 22–206.doi: 10.28996/1680–4422–2017–1–22–206. Clinical Practical Recommendations of KDIGO 2012 on Diagnosis and Treatment of Chronic Kidney Disease. Nephrology and dialysis, 2017, Vol. 19, No. 1, pp. 22–206 (in Russian). doi: 10.28996 / 1680–4422– 2017–1–22–206.
5. Mercadante S., Caraceni A. Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med, 2011, 25(5), рp. 504–15. doi: 10.1177/0269216311406577.
6. Koulouris A.I., Banim P., Hart A. R. Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments. Dig Dis Sci. 2017, 62(4), рp. 861–870. doi: 10.1007/s10620–017–4488-z.
7. Dean L. Tramadol Therapy and CYP2D6 Genotype. In: S. Douglas, S. Lathrop, Medical Genetics Summaries Medical Genetics Summaries. National Center for Biotechnology Information (US) Bethesda (MD). 2018, рp. 419–429
Review
For citations:
Bobrova O.P., Schneider N.A., Petrova M.M., Dmitrenko D.V., Zyryanov S.K., Zobova S.N. Efficiency and safety of opioid therapy of chronic pain syndrome in patients with cancer of the refractory iron: clinico-pathogenetic features. Experimental and Clinical Gastroenterology. 2019;1(10):45-51. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-170-10-45-51
Views:
474
Email this article 